Dermata Therapeutics Inc (NASDAQ: DRMA): Retirees Don’t Worry About Volatility

Dermata Therapeutics Inc (NASDAQ:DRMA) currently has a daily average trading volume of 1.17M but it saw 22511802 shares traded in last market. With a market cap of 1.71M USD, the company’s current market price of $2.48 came rising about 44.19 while comparing to the previous closing price of $1.72. In past 52 weeks, the stock remained buoying in the range of price level as high as $21.60 and as low as $1.29.

Taking a look at 20-day trading activity of Dermata Therapeutics Inc (DRMA) gives us an average price of $2.1100, while its current price level is -88.52% below from 52-week high level whereas it is 92.25% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.6600 while that of 200 days or SMA-200 reads an average of $6.4300. A closer look into the stock’s movement over the week reveals that its volatility is standing at 25.76% during that period while stretching the period over a month that increases to 28.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.72 which implies that the stock is in neutral territory.

Over the week, DRMA’s stock price is moving -3.88% down while it is 11.21% when we observe its performance for the past one month. Year-to-date it is -72.90% down and over the past year, the stock is showing a downside performance of -86.98%.

The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -9.45 beat the consensus estimate of -13.8 for the same.

Currently, Dermata Therapeutics Inc’s total number of outstanding shares is 0.69M with 2.47% of that held by the insiders while 1.74% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -228.17% and return on equity (ROE) at -146.08%. Stock’s beta reads 0.74. Stock has a price to book (P/B) ratio of 0.29. Its return on asset (ROA) is -120.05% on average.